Yoshida et al., demonstrated the higher expression of MRP5 in doxorubicin-resistant human lung cancer cell lines, as well as its overexpression due to 48 h of exposure to doxorubicin, indicating its role in both intrinsic and acquired doxorubicin resistance [45]. The gene discussed is ABCC5; the disease is lung cancer.